Zofenopril: Difference between revisions

Jump to navigation Jump to search
m (Protected "Zofenopril": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{CMG}}
{{EH}}
{{Drugbox
{{Drugbox
| IUPAC_name        = (2''S'',4''S'')-1-[(2''S'')-3-(Benzoylsulfanyl)-2-methylpropanoyl]-4-phenylsulfanylpyrrolidine-2-carboxylic acid
| IUPAC_name        = (2''S'',4''S'')-1-[(2''S'')-3-(Benzoylsulfanyl)-2-methylpropanoyl]-4-phenylsulfanylpyrrolidine-2-carboxylic acid
Line 31: Line 27:
| routes_of_administration = Oral
| routes_of_administration = Oral
}}
}}
__NOTOC__
{{SI}}
{{CMG}}


'''Zofenopril''' (also known as Zofenoprilum [Latin]) is an [[ACE inhibitor|angiotensin converting enzyme (ACE) inhibitor]] which is indicated for the treatment of hypertension.  
==Overview==
'''Zofenopril''' (also known as Zofenoprilum [Latin]) is an [[ACE inhibitor|angiotensin converting enzyme (ACE) inhibitor]] with cardioprotective properties indicated for the treatment of hypertension.<ref>{{cite journal |author=Ambrosioni E |title=Defining the role of zofenopril in the management of hypertension and ischemic heart disorders |journal=Am J Cardiovasc Drugs |volume=7 |issue=1 |pages=17–24 |year=2007 |pmid=17355163 |doi= 10.2165/00129784-200707010-00002|url=}}</ref>
 
In small studies, zofenopril appeared [[statistical significance|significantly]] more effective than the older antihypertensives [[atenolol]] and [[enalapril]], and was associated with less [[adverse drug reaction|adverse effect]]s.<ref>{{cite journal |author=Nilsson P |title=Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension |journal=Blood Press Suppl |volume=2 |issue= |pages=25–30 |date=October 2007 |pmid=18046976 |doi= |url=}}</ref><ref>{{cite journal |author=Mallion JM |title=An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension |journal=Blood Press Suppl |volume=2 |issue= |pages=13–8 |date=October 2007 |pmid=18046974 |doi= |url=}}</ref>
 
==References==
{{Reflist|2}}


{{ACE inhibitors}}
{{ACE inhibitors}}


[[Category:ACE inhibitors]]
[[Category:ACE inhibitors]]
 
[[Category:Cardiovascular Drugs]]
{{WH}}
[[Category:Drug]]
{{WS}}

Latest revision as of 21:01, 23 July 2014

Zofenopril
Clinical data
Routes of
administration
Oral
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H23NO4S2
Molar mass429.552 g/mol

WikiDoc Resources for Zofenopril

Articles

Most recent articles on Zofenopril

Most cited articles on Zofenopril

Review articles on Zofenopril

Articles on Zofenopril in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Zofenopril

Images of Zofenopril

Photos of Zofenopril

Podcasts & MP3s on Zofenopril

Videos on Zofenopril

Evidence Based Medicine

Cochrane Collaboration on Zofenopril

Bandolier on Zofenopril

TRIP on Zofenopril

Clinical Trials

Ongoing Trials on Zofenopril at Clinical Trials.gov

Trial results on Zofenopril

Clinical Trials on Zofenopril at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Zofenopril

NICE Guidance on Zofenopril

NHS PRODIGY Guidance

FDA on Zofenopril

CDC on Zofenopril

Books

Books on Zofenopril

News

Zofenopril in the news

Be alerted to news on Zofenopril

News trends on Zofenopril

Commentary

Blogs on Zofenopril

Definitions

Definitions of Zofenopril

Patient Resources / Community

Patient resources on Zofenopril

Discussion groups on Zofenopril

Patient Handouts on Zofenopril

Directions to Hospitals Treating Zofenopril

Risk calculators and risk factors for Zofenopril

Healthcare Provider Resources

Symptoms of Zofenopril

Causes & Risk Factors for Zofenopril

Diagnostic studies for Zofenopril

Treatment of Zofenopril

Continuing Medical Education (CME)

CME Programs on Zofenopril

International

Zofenopril en Espanol

Zofenopril en Francais

Business

Zofenopril in the Marketplace

Patents on Zofenopril

Experimental / Informatics

List of terms related to Zofenopril

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Zofenopril (also known as Zofenoprilum [Latin]) is an angiotensin converting enzyme (ACE) inhibitor with cardioprotective properties indicated for the treatment of hypertension.[1]

In small studies, zofenopril appeared significantly more effective than the older antihypertensives atenolol and enalapril, and was associated with less adverse effects.[2][3]

References

  1. Ambrosioni E (2007). "Defining the role of zofenopril in the management of hypertension and ischemic heart disorders". Am J Cardiovasc Drugs. 7 (1): 17–24. doi:10.2165/00129784-200707010-00002. PMID 17355163.
  2. Nilsson P (October 2007). "Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension". Blood Press Suppl. 2: 25–30. PMID 18046976.
  3. Mallion JM (October 2007). "An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension". Blood Press Suppl. 2: 13–8. PMID 18046974.

Template:ACE inhibitors